Literature DB >> 3284455

Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro.

P Druilhe1, O Brandicourt, T Chongsuphajaisiddhi, J Berthe.   

Abstract

In vitro studies with quinine, quinidine, cinchonine, and cinchonidine showed that despite a similarity of chemical structure, the effectiveness of these cinchona bark alkaloids against several culture lines of Plasmodium falciparum varied widely. Depending on the strain tested, quinidine and cinchonine were 1 to 10 and 1 to 5 times, respectively, more active than quinine. A combination made of equal parts of quinine, quinidine, and cinchonine was found to have several interesting features; it had activity similar to that of quinine against quinine-susceptible strains but was found to be 2 to 10 times more effective against strains resistant to quinine and had a more consistent effect than any of the alkaloids used singly. The potentiation was found to depend mainly on the presence of cinchonine in the mixtures studied. Synergism was also confirmed in a study of 25 P. falciparum strains isolated from Thai patients. Combinations of cinchona bark alkaloids could thus be of interest in areas where P. falciparum is becoming less susceptible to quinine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284455      PMCID: PMC172144          DOI: 10.1128/AAC.32.2.250

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Quinine-tetracycline and quinine-bactrim treatment of acute falciparum malaria in Thailand.

Authors:  E J Colwell; R L Hickman; S Kosakal
Journal:  Ann Trop Med Parasitol       Date:  1973-06

2.  Plasmodium falciparum drug resistance in West Africa.

Authors:  P Druilhe; P Brasseur; O Brandicourt; J Kouamouo; D Richard-Lenoble; F Diouf; F Gay; R S Moyou; M Danis; M Y Kombila
Journal:  Ann Soc Belg Med Trop       Date:  1986

3.  Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum.

Authors:  F Verdier; J Le Bras; F Clavier; I Hatin
Journal:  Lancet       Date:  1984-05-26       Impact factor: 79.321

4.  Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment.

Authors:  I C Bygbjerg; A Schapira; H Flachs; G Gomme; S Jepsen
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

5.  Type II mefloquine resistance in Thailand.

Authors:  E F Boudreau; H K Webster; K Pavanand; L Thosingha
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

6.  Treatment of quinine resistant falciparum malaria in Thai children.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Attanath
Journal:  Southeast Asian J Trop Med Public Health       Date:  1983-09       Impact factor: 0.267

7.  Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.

Authors:  U Hess; P M Timmermans; M Jones
Journal:  Am J Trop Med Hyg       Date:  1983-03       Impact factor: 2.345

8.  Quinidine in falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; T Chongsuphajaisiddhi; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

9.  Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.

Authors:  W M Watkins; D G Sixsmith; H C Spencer; D A Boriga; D M Kariuki; T Kipingor; D K Koech
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

10.  One-step Plasmodium falciparum cultivation--application to in-vitro drug testing.

Authors:  P Druilhe; D Mazier; O Brandicourt; M Gentilini
Journal:  Tropenmed Parasitol       Date:  1983-12
View more
  10 in total

1.  Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.

Authors:  H Barennes; H Sterlingot; N Nagot; H Meda; M Kaboré; M Sanou; B Nacro; P Bourée; E Pussard
Journal:  Eur J Clin Pharmacol       Date:  2003-01-29       Impact factor: 2.953

2.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.

Authors:  S T Mariga; J P Gil; C Sisowath; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 5.  Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions.

Authors:  Philippe Rasoanaivo; Colin W Wright; Merlin L Willcox; Ben Gilbert
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

6.  Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.

Authors:  Carol E Griffin; Jonathan M Hoke; Upeka Samarakoon; Junhui Duan; Jianbing Mu; Michael T Ferdig; David C Warhurst; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

Review 7.  Natural products as starting points for future anti-malarial therapies: going back to our roots?

Authors:  Timothy N C Wells
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

Review 8.  A call for using natural compounds in the development of new antimalarial treatments - an introduction.

Authors:  Hagai Ginsburg; Eric Deharo
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

9.  Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.

Authors:  Edna Ooko; Onat Kadioglu; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-02       Impact factor: 5.810

10.  Supplementation of Plants with Immunomodulatory Properties during Pregnancy and Lactation-Maternal and Offspring Health Effects.

Authors:  Aneta Lewicka; Łukasz Szymański; Kamila Rusiecka; Anna Kucza; Anna Jakubczyk; Robert Zdanowski; Sławomir Lewicki
Journal:  Nutrients       Date:  2019-08-20       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.